SLC5A2 and heart failure: In the meantime, substances like ACE-inhibitors, aldosterone antagonists, ARNI and, most recently, SGLT-2 inhibitors have revolutionized medical heart failure therapy, as they have been demonstrated to be able to reduce both heart-failure-related events and mortality [13,14,15].